Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Name: Bain Capital Life Sciences Investors, LLC Q4 2017 13F Filing | 13F Explorer
Creator: Bain Capital Life Sciences Investors, LLC
Published: 2018-02-14

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q4 2017 (Next →)

Filing Date: Feb 14, 2018

Total Value: $152M (100.0% shares, 0.0% debt)

Holdings (3)

— DICERNA PHARMACEUTICALS INC 52.9%

Value $80.64M Shares 8,930,237 Est. Cost $9.03 Unrealized —

IFRX INFLARX NV 25.8%

Value $39.31M Shares 1,876,413 Est. Cost $17.97 Unrealized 0.0%

— MARINUS PHARMACEUTICALS INC 21.3%

Value $32.46M Shares 3,977,453 Est. Cost $8.16 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	DICERNA PHARMACEUTICALS INC	8,930,237	$80.64M	52.9%	$9.03	—	COM	253031108
IFRX	INFLARX NV	1,876,413	$39.31M	25.8%	$17.97	0.0%	COM	N44821101
—	MARINUS PHARMACEUTICALS INC	3,977,453	$32.46M	21.3%	$8.16	—	COM	56854Q101